Pharmacies sue to stop Pfizer/Wyeth deal

Seven California pharmacies don't want to see Pfizer's $68 billion buyout of Wyeth succeed, and they've filed suit against the drugmaker to protest the deal. Four of the five banks that provided the $22 billion loan to finance the deal were beneficiaries of the Troubled Asset Relief Program funds, claims Golden Gate Pharmacy Services. The group objects to the fact that government bailout money would be used to finance a buyout that will result in the loss of some 22,000 jobs. In addition to job cuts, Golden Gate says the deal will lead to less competition for certain drugs and give pharmacies fewer supplier choices.

A Pfizer spokesperson told Bloomberg that the company hasn't been served with the lawsuit, but believes the complaint, which was filed in a San Francisco federal court, is without merit.

- here's the Bloomberg report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.